Showing results (351-360 of 557) with videos related to
Sort By:
Pageof 56
Cancers|February 27, 2026
Identification of the Carcinogenic Process from Lobular Endocervical Glandular Hyperplasia to Gastric-Type Adenocarcinoma of the Uterine Cervix via Whole-Exome SequencingAiri Kuruma, Tatsuo Masuda, Kazuaki Sato, et al.Biological & Pharmaceutical Bulletin|December 5, 2017
Evaluation of Drug-Induced Photosensitivity Using the Japanese Adverse Drug Event Report (JADER) DatabaseSatoshi Nakao, Haruna Hatahira, Sayaka Sasaoka, et al.Journal of Pharmaceutical Health Care and Sciences|December 22, 2018
Analysis of fall-related adverse events among older adults using the Japanese Adverse Drug Event Report (JADER) databaseHaruna Hatahira, Shiori Hasegawa, Sayaka Sasaoka, et al.Journal of Virological Methods|October 2, 2015
Next-generation sequencing (NGS) in the identification of encephalitis-causing viruses: Unexpected detection of human herpesvirus 1 while searching for RNA pathogensKarol Perlejewski, Marta Popiel, Tomasz Laskus, et al.Cancer Science|January 30, 2024
Genome-wide loss-of-function genetic screen identifies INSIG2 as the vulnerability of hepatitis B virus-integrated hepatoma cellsMakoto Fukuoka, Takahiro Kodama, Kazuhiro Murai, et al.Pathology, Research and Practice|January 5, 2025
Spatial transcriptome analysis of lung squamous cell carcinoma arising from interstitial pneumonia provides insights into tumor heterogeneityKoto Ukon, Satoshi Nojima, Daisuke Motooka, et al.Journal of Virological Methods|February 16, 2023
Impact of G29179T mutation on two commercial PCR assays for SARS-CoV-2 detectionWakaki Kami, Takeshi Kinjo, Hiroe Hashioka, et al.Journal of Thoracic Disease|December 11, 2025
Phase 2 feasibility study of adjuvant chemotherapy with cisplatin (CDDP) and TS-1, followed by alternate-day TS-1 maintenance therapy, in patients with completely resected pathological stage II-IIIA non-small cell lung cancerKosuke Fujino, Riichiroh Maruyama, Takashi Marutsuka, et al.Scientific Reports|July 7, 2025
Differences in gut microbiome between autosomal dominant polycystic kidney disease with and without intracranial aneurysmsTatsumaru Fukuda, Masatoshi Takagaki, Junya Kaimori, et al.SAGE Open Medicine|March 20, 2019
Adverse event profiles of solvent-based and nanoparticle albumin-bound paclitaxel formulations using the Food and Drug Administration Adverse Event Reporting SystemMisa Naganuma, Kohei Tahara, Shiori Hasegawa, et al.Pageof 56